Implantable Cardioverter Defibrillator (ICD)

This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).

Heart Rhythm 2019 study shows travelers with common cardiac devices can pass through without restrictions or precautions. HRS 2019, #HRS #HRS19

A new study shows travelers with common cardiac devices can pass through airport body scanners without restrictions or precautions.

News | EP Lab | May 14, 2019

Airport Security Body Scanners Do Not Interfere With Pacemakers, ICDs

May 14, 2019 – Results from new research show that passengers with cardiac implantable electronic devices (CIEDs), such...

News | Implantable Cardioverter Defibrillator (ICD) | May 13, 2019

Emblem Subcutaneous ICD Safe and Effective for Majority of Patients

May 13, 2019 — Boston Scientific announced acute results from the UNTOUCHED study evaluating safety and efficacy of the...

News | EP Lab | May 13, 2019

Survey Shows Big Need for Patient Education on Their Implantable Electrophysiology Devices

May 13, 2019 – Results from a new survey are the first to report a large discrepancy in patient’s knowledge of their...

A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system showed it can be implanted with no major complications, and can sense, pace and defibrillate the heart.

Medtronic's investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system.

News | May 13, 2019

First-in-human Study Positive of Medtronic Extravascular ICD System

May 13, 2019 – A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter...

News | Cardiac Resynchronization Therapy Devices (CRT) | April 29, 2019

Biotronik Launches Acticor DX and CRT-DX Devices in U.S.

April 29, 2019 — Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX and...

News | Cardiac Resynchronization Therapy Devices (CRT) | April 18, 2019

Biotronik Launches Acticor and Rivacor ICD and CRT-D Devices in Europe

April 18, 2019 – Biotronik announced the European market release of what it calls the world’s smallest implantable...

Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.

Concerto CRT-D and Virtuoso ICD implantable cardiac devices are among several Medtronic electrophysiology devices included in a safety alert because of their lack of cybersecurity measures to avoid hacking, according to the FDA.

Feature | EP Lab | March 22, 2019

FDA Issues Safety Alert on Cybersecurity Vulnerabilities of Medtronic ICD, CRT Devices

March 22, 2019 — The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare...

Videos | EP Lab | March 21, 2019

VIDEO: Use of an Antibacterial Envelope to Reduce Infections for Pacemakers, ICDs

Khaldoun Tarakji, M.D., MPH, associate section head, section of electrophysiology and pacing in the Robert and Suzanne...

An implanted ICD showing its three venous leads. These multiple CRT leads can cause issues when they need to be replaced and are abandoned with new leads put over them in the SVC, which may require lead extraction.

An implanted ICD showing its three leads in the venous system.

Feature | EP Lab | January 13, 2019 | Dave Fornell, Editor

New Approaches to EP Lead Management

To extract or abandon broken or infected implantable, venous electrophysiology (EP) device leads has been a debate for...

Medtronic is issuing a software update to address a safety risk caused by cybersecurity vulnerabilities associated with the internet connection between the Carelink 2090 and Carelink Encore 29901 programmers used to download software from the Medtronic software distribution network (SDN) . This update is a voluntary recall correction by the manufacturer to address the safety risk caused by the cybersecurity vulnerability.

Medtronic is issuing a software update to address a safety risk caused by cybersecurity vulnerabilities associated with the internet connection between the Carelink 2090 and Carelink Encore 29901 implantable EP device programmers.

Feature | Cybersecurity | October 17, 2018

FDA Says Medtronic is Updating Cybersecurity Vulnerabilities of its Implantable Cardiac Device Programmers

October 17, 2018 — The U.S. Food and Drug Administration (FDA) has reviewed information about potential cybersecurity...